Condition
Diabetic Gastroparesis
ClinicalTrials.gov condition label
Clinical trials
10 shownCorrelation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes GastroparesisNCT07324785 · 2026-01-07
RECRUITINGWashed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety StudyNCT06340828 · 2024-04-20
NOT_YET_RECRUITINGMulticenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic GastroparesisNCT02025751 · 2014-04-01
COMPLETEDDiabetic Gastroparesis Efficacy/Safety Study of TZP-102NCT01664637 · 2012-08-01
TERMINATEDPilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and GastroparesisNCT01607684 · 2012-01-01
COMPLETEDContinuous Glucose Monitoring and Insulin Pump Therapy in Diabetic GastroparesisNCT01030341 · 2011-05-01
COMPLETEDDaily Tadalafil and Gastric Emptying Time in Diabetic GastroparesisNCT01326117 · 2011-04-01
WITHDRAWNAcupuncture for Diabetic GastroparesisNCT00470795 · 2009-06-01
SUSPENDEDEfficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With GastroparesisNCT00845858 · 2009-04-01
COMPLETEDEvaluation of Diagnostic Methods and Dietary Treatment of Diabetic GastroparesisNCT01557296 · 2007-09-01
COMPLETEDCommon interventions
PlaceboDRUG210 mg TZP-102DRUG1AcupunctureOTHER1Can the motility be improvedOTHER1CGMS and insulin pumpDEVICE1dietary treatment: food of small particle sizeDIETARY_SUPPLEMENT1Magnetic Marker Imaging (MMI) with Magma 3D systemDEVICE1metoclopramideDRUG1Metoclopramide Nasal SprayDRUG1Placebo Nasal SprayDRUG1placebo/sham acupuncturePROCEDURE1postprandial plasma glucoseBIOLOGICAL1tadalafilDRUG1Validate X-ray diagnostic method.RADIATION1Washing Microbiota TransplantationOTHER1
Leading sponsors
Trial status mix
COMPLETED5
NOT_YET_RECRUITING1
RECRUITING1
SUSPENDED1
TERMINATED1
WITHDRAWN1
Phase mix
PHASE24
NA2
PHASE32
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.